Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 3 Combination evidence-based therapies reduce mortality to 1 year following myocardial infarction independent of renal function. Patients receiving multiple clinical practice guideline-adherent medications (antiplatelet agents, beta-blockers, lipid-lowering agents, angiotensin-converting enzyme inhibitors) enjoy incremental survival benefit. Adapted from Tay et al. (62). GFR = glomerular filtration rate; CI = confidence interval.
|
